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Edited by Berend WieringaAbstract Regulation of growth factor dependent cell survival is
crucial for development and disease progression. Here, we report
a novel function of Src kinases as a negative regulator of plate-
let-derived growth factor (PDGF) dependent cell survival. We
characterized a series of PDGF a receptor (PDGFRA) mutants,
which lack the binding sites for Src, phosphatidylinositol 3 0-ki-
nase (PI3K), SHP-2 or phospholipase C-c. We found that
PDGFRA-dependent cell survival was mainly mediated through
activation of PI3K, and was negatively regulated by Src. Char-
acterization of the downstream signaling events revealed that
PI3K activates the protein kinase Akt, which in turn phosphory-
lates and thus inactivates proapoptotic Forkhead transcription
factors. Src phosphorylates the ubiquitin-ligase c-Cbl, which is
required for degradation of the activated receptor. Consequently,
overexpression of c-Cbl prevented PDGFRA-mediated cell sur-
vival, whereas it did not aﬀect this response, when Src was unable
to associate with the receptor. This novel function of Src in anti-
apoptotic signaling introduces Src kinases as an interesting ther-
apeutic target in apoptosis related diseases.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Peptide growth factors such as platelet-derived growth fac-
tor (PDGF) play a pivotal role during embryonic development
and promote the onset and progression of proliferative dis-
eases [1]. PDGF induces cellular events such as cell prolifera-
tion, migration and cellular survival via two subtypes of
receptor tyrosine kinases (RTKs), which elicit their responses
through binding and activation of Src homology 2 (SH2)
domain containing signaling molecules. Upon ligand binding,Abbreviations: Src, Src family kinases; PI3K, phosphatidylinositol 30-
kinase; PLC-c, phospholipase C-c1; PDGF, platelet-derived growth
factor; PDGFR, platelet-derived growth factor receptor; RTK, recep-
tor tyrosine kinases; IGF-I, insulin-like growth factor I; STAT, signal
transducer and activator of transcription; ELISA, enzyme-linked im-
munosorbent assay
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doi:10.1016/j.febslet.2006.11.034RTKs dimerize, autophosphorylate, and the phosphorylated
tyrosine residues serve as a key component of the docking sites
for SH2 domain-containing signal relay enzymes [2]. In this
paper, we focus on the PDGF a receptor (PDGFRA) subtype
since this receptor is crucial for many physiological as well as
pathophysiological mechanisms [1].
Activation of the PDGFRA results in its phosphorylation at
numerous tyrosine residues, and eight major phosphorylation
sites have been identiﬁed [1]. Once activated the PDGFRA
recruits and activates Src family kinases (Src), the phospho-
tyrosine phosphatase SHP-2, phosphatidylinositol 3-kinase
(PI3K), and phospholipase C-c1 (PLC-c). We have previously
shown that PDGF-AA-induced proliferation is solely medi-
ated by PI3K, whereas multiple signaling enzymes (Src,
PI3K and PLC-c) are required for eﬃcient PDGFRA-medi-
ated cell migration [3]. In addition to proliferation and chemo-
taxis, the regulation of apoptosis plays a critical role in
development and disease progression. Mice carrying a targeted
null mutation in the PDGFRA gene die during embryogenesis
and display increased apoptosis indicating that the PDGFRA
functions during early development by aﬀecting cellular sur-
vival [4]. However, PDGFRA-mediated eﬀects on cell survival
are poorly understood, thus the characterization of the signal-
ing pathways that regulate protection from apoptosis is of
major importance.
All of the signaling enzymes that are recruited to the acti-
vated PDGFRA are principally able to mediate survival sig-
nals. Several studies have demonstrated that Src, PI3K,
SHP-2, and PLC-c are able to exert antiapoptotic properties
in diﬀerent cellular systems, but their relative importance for
PDGFRA-mediated cell survival has not been characterized.
PI3K mediates antiapoptotic signals of several growth factors
via activation of its downstream target Akt [5,6], which phos-
phorylates and thus inactivates several proapoptotic proteins
such as BAD [7], Forkhead transcription factors or caspase 9
[8,9]. PLC-c exerts antiapoptotic properties via protein kinase
C (PKC)-dependent phosphorylation of Bcl-2 proteins such as
Bcl-2 and BAD [10–13]. SHP-2 was shown to be essential for
insulin-like growth factor I (IGF-I)- or PDGF-mediated cell
survival as it suppresses Caspase 3-dependent apoptosis in
ﬁbroblasts [12]. Another well characterized survival pathway
is the Ras/Raf/extracellular-regulated kinase (Erk) cascade,
which leads to the phosphorylation of BAD [14,15]. Finally,
Src family kinases activate signal transducers and activators
of transcription (STATs), which protects ﬁbroblasts from
apoptosis [16–18].ation of European Biochemical Societies.
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enzymes that are recruited to the activated PDGFRA for
PDGF-dependent regulation of apoptosis. Our approach was
to characterize tyrosine to phenylalanine PDGFRA mutants
that failed to associate with one or more of the signaling en-
zymes. The use of this highly eﬃcient system allowed us to
selectively activate individual signaling molecules that are
recruited to the ligand-stimulated PDGFRA, and to compare
the ability of the various mutants to protect against apoptosis.2. Materials and methods
2.1. Cell lines
Ph-cells and their maintenance were previously described [19,20].
The human WT and mutant PDGFRA were stably expressed in Ph-
cells to approximately 1 · 105 receptors per cell, using the pLNCX2 ret-
roviral vector [19,21]. DNA constructs were transfected into 293GPG
cells [22], the viral supernatant collected for 7 days, and concentrated
by centrifugation (25000 · g, 90 min, 4 C). The virus was titered, and
equal amounts of colony forming units were used to infect Ph-cells.
The infected cells were selected in the presence of 1 mg/ml G418, and
mass populations of drug-resistant cells were used in all of the experi-
ments. The WT c-Cbl construct (kindly provided by Dr. Hamid Band)
was subcloned into the pLHDCX3 retroviral vector, whose polylinker
contains the following unique restriction sites:HindIII, SalI, BglII, and
NotI. The c-Cbl construct in the retroviral vector was transfected into
293GPG cells [22], the viral supernatant collected for 7 days, and con-
centrated by centrifugation (25000 · g, 90 min, 4 C). Equal amounts
of colony forming units from the concentrated virus were used to infect
Ph-cells expressing either WT or F72/74 mutant receptors.
2.2. Antibodies, materials
The rabbit polyclonal PDGFRA antibodies recognize either the car-
boxyl terminus (27P) or a portion of the ﬁrst immunoglobulin domain
(80.8) of the human PDGFRA [19]. The c-Cbl antibody used for
immunoprecipitation and Western blot analysis of c-Cbl was pur-
chased from Santa Cruz (C-15; sc-170). For anti-phospho-Akt Western
blot analysis, a phospho-speciﬁc Akt (Ser473) antibody purchased
from Cell Signaling (#9271S) was used at a 1:1000 dilution. Akt Wes-
tern blot analysis was performed using a polyclonal anti-Akt antibody
(Cell Signaling, #9272) at a 1:1000 dilution. Phosphorylation of
Forkhead transcription factors was analysed using a Phospho-FKHR
(Thr24)/FKHRL1 (Thr32) antibody (Cell Signaling, #9464S). PDGF-
AA was purchased from Promo Cell (Heidelberg, Germany).
2.3. Detection of apoptosis
A Cell Death Detection ELISA (Roche Diagnostics) was used to
determine cell death. The method relies on the detection of cytoplasmic
histone-associated DNA fragments (mono- and oligonucleosomes)
that are generated in apoptotic cells. Cells (50000) were placed into
each well of a 24-well plate. Cells were plated in DMEM containing
10% FCS. Twelve hours later Ph-cells were starved in DMEM contain-
ing 0.1% FCS for 24 h. To assess the antiapoptotic eﬀect of PDGF-AA
medium was changed to DMEM containing 100 lM H2O2 in the pres-
ence or absence of 50 ng/ml PDGF-AA. After 12 h the cell lysate was
collected, and the amount of cell death was evaluated using the Cell
Death Detection ELISA assay as described in detail by the manufac-
turer.
2.4. Phosphorylation of Akt and Forkhead transcription factors
Phospho-speciﬁc antibodies were used to detect the activated form
of Akt and the phosphorylated forms of the Akt-substrates FKHR
and FKHRL1. Ph-cells expressing the WT or mutant PDGF receptors
were grown to 85–90% conﬂuence, serum starved in DMEM contain-
ing 0.1% FCS for 18–24 h, and were either left resting or stimulated
with PDGF-AA at 37 C for times indicated. The cells were washed
with H/S (25 mM HEPES, pH 7.4, 150 mM NaCl, 2 mM Na3VO4),
lysed in EB (10 mM Tris–HCl, pH 7.4, 5 mM EDTA, 50 mM NaCl,
50 mM sodium ﬂuoride, 1% Triton X-100, 1 mM phenylmethylsul-
fonyl ﬂuoride, 2 mM Na3VO4, and 20 lg/ml aprotinin), and centri-fuged to remove insoluble debris. The lysates were subjected to a
bicinchoninic acid (BCA) protein assay (Pierce), and equal amounts
of protein were resolved on a 10% SDS–PAGE gel and transferred
to PVDF membranes. Blots were blocked in 5% non-fat dry milk/
TBS, and probed over night using either a Phospho-Akt (Ser473), an
Akt or a Phospho-FKHR (Thr24)/FKHRL1 (Thr32) antibody (Cell
Signaling). After incubation with horseradish peroxidase-conjugated
goat anti-rabbit IgG (Amersham), antigen–antibody complexes were
visualized by enhanced chemiluminescence according to the instruc-
tions of the manufacturer (Amersham).
2.5. In vitro phosphorylation of c-Cbl
c-Cbl was immunoprecipitated from serum-deprived Ph-cells, and c-
Cbl- or mock-immunoprecipitates were incubated with various con-
centrations of active Src in an in vitro-kinase-assay in the presence
of [c-32P]ATP. Where indicated the Src inhibitor PP1 was added.
The signals were visualized via autoradiography.
2.6. Statistical analysis
All data are expressed as means ± S.D. Statistical analysis was eval-
uated by non-parametric analysis. P < 0.05 was considered signiﬁcant.3. Results
3.1. Identiﬁcation of the signal relay molecules that regulate
antiapoptotic signaling by the PDGFRA
To systematically evaluate the role of each of the signaling
molecules for PDGFRA-mediated cellular survival in a single
cell line, we created a series of PDGFRA mutants in which the
tyrosine residues required for the recruitment of either one of
the PDGFRA-associated signaling enzymes to the activated
receptor were mutated to phenylalanine (subtraction mutants)
(Fig. 1A) [3]. A second set of PDGFRA mutants (add-back
mutants) included the F7 receptor, in which all seven tyrosine
phosphorylation sites were mutated, as well as a panel of
receptors that have the tyrosine residue(s) required for binding
of one of the associated proteins restored (Fig. 1B). All mutant
receptors were stably expressed in Ph-cells, a 3T3-like cell line
that expresses normal levels of the PDGFRB, but no endoge-
nous PDGFRA [23]. Hence, it is possible to activate each spe-
ciﬁc PDGFRA mutant without stimulation of endogenous
PDGFRA.
We induced apoptosis by treatment of quiescent cells with
100 lM H2O2. Stimulation of Ph-cells expressing the WT
receptor with H2O2 caused an 8-fold increase of apoptotic cell
death compared to non-stimulated cells as assessed by Cell
Death Detection ELISA. Activation of the WT-PDGFRA
with 50 ng/ml PDGF-AA (12 h) led to a 20.1 ± 8.2% reduction
of apoptosis (P < 0.05) (Fig. 2). PDGF-AA did not exert an
antiapoptotic eﬀect in naı¨ve Ph-cells, which do not express
PDGFRA, whereas PDGF-BB reduced apoptosis by 29.6 ±
7.4%, as expected (data not shown). To rule out that our
observations were limited to one speciﬁc apoptosis inducer,
we additionally used UV irradiation and obtained similar re-
sults (data not shown). To investigate the role of each of the
signaling molecules for PDGF-AA-induced protection from
apoptosis, we compared this response in Ph-cells expressing
either the WT-PDGFRA or the various mutant receptors.
As shown in Fig. 3A, deletion of the binding site for PI3K
or SHP-2 as well as the Y to F exchange at position 988 com-
pletely suppressed the antiapoptotic eﬀect, whereas activation
of the F72/74 receptor, which lacks the Src binding site, led
to enhanced cellular survival (54.8 ± 4.0% reduction of apop-
tosis, P < 0.01) as compared to the WT receptor (P < 0.05
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Fig. 1. Schematic diagram illustrating the series of PDGFRA mutants used in this study [3]. The cytoplasmic domain of the PDGFRA is shown as a
schematic in which the tyrosine phosphorylation sites are represented as P, and Tyr to Phe substitutions are indicated as black squares. Signaling
enzymes predicted to stably associate with the receptor mutants are indicated by geometric shapes and are identiﬁed at the top of the schemes. The
nomenclature of the ‘‘subtraction panel’’ (A) and ‘‘add-back panel’’ (B) of PDGFRA mutants is indicated to the right of each receptor
representation. In the subtraction panel, the names indicate which of the tyrosine residues have been replaced with phenylalanine, and in the add-
back panel the name of each mutant denotes which of the mutations in the F7 construct has been repaired. Tyr 572 and 574 are located in the
juxtamembrane domain (JM) of the receptor and are required for Src binding to the receptor; Tyr 720, 731, and 742 are in the kinase insert (KI) of
the receptor and are responsible for SHP-2 and PI3K binding, respectively; Tyr 988 and 1018 are located in the Tail of the receptor, and are involved
in the binding of a yet unidentiﬁed protein and PLC-c, respectively.
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Fig. 2. PDGF-AA inhibits H2O2-induced apoptosis. Shown is a
quantitative analysis of apoptosis of Ph-cells expressing the WT-
PDGFRA by cell death detection ELISA. Cells were starved over
night and left untreated or were incubated for 12 h with 100 lM H2O2
with or without 50 ng/ml PDGF-AA. Data were measured in
triplicates and normalized by the apoptosis rate of H2O2 treated cells
in the absence of PDGF-AA. Data represent mean values ± S.D. from
at least three independent experiments (*P < 0.05, H2O2 alone vs.
H2O2 and PDGF-AA-treated cells).
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analyzed, it appeared that activation of only PI3 kinase with-
out activation of Src, SHP-2 and PLC-c was suﬃcient for
the complete PDGF-AA-induced antiapoptotic eﬀect. In
contrast, restoration of the binding sites of Src, SHP-2, or
PLC-c as well as Y988 alone did not inﬂuence cellular sur-vival (Fig. 3B). Thus, PI3K is necessary and suﬃcient for
PDGFRA-dependent antiapoptotic signaling.
3.2. PI3K mediates cellular survival via Akt and Forkhead
transcription factors
Activation of Akt is thought to play a critical role in PI3K-
mediated cellular survival. To investigate the role of the recep-
tor-associated proteins for PDGF-induced Akt activation, we
monitored this response in WT and mutant PDGFRA express-
ing cells. The cells were grown to subconﬂuence, arrested by
serum starvation, and were left resting or stimulated with
50 ng/ml PDGF-AA for 5 min. The cells were washed, lysed,
equal amounts of protein were resolved on a 10% SDS–poly-
acrylamide electrophoresis gel, and subjected to Western blot
analysis using a phospho-Akt-speciﬁc antibody. Stimulation
of the WT receptor with PDGF-AA resulted in a robust phos-
phorylation of Akt. The F31/42 receptor activated Akt poorly,
whereas the tyrosine to phenylalanine substitution at all other
sites had no eﬀect on PDGF-dependent activation of Akt
(Fig. 4A). Similar ﬁndings were obtained when cells expressing
the add-back panel of receptor mutants were analyzed. As
expected, PDGF-induced Akt activation was completely abol-
ished in the F7 receptor expressing cells (Fig. 4B). Restoration
of the binding sites for PI3K fully rescued PDGF-dependent
activation of Akt, whereas the Y72/74, Y720, Y988, and
Y1018 mutants were not able to induce eﬃcient Akt activa-
tion. Hence, these ﬁndings indicate that only PI3K contributes
to PDGFRA-mediated Akt activation.
To further investigate the signaling mechanisms down-
stream of PI3K/Akt, we evaluated the PDGF-AA-dependent
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Fig. 3. PDGF-AA inhibits H2O2-induced apoptosis in a PI3K-dependent manner. Quantitative analysis of apoptosis of Ph-cells expressing
PDGFRA mutants was assessed by cell death detection ELISA. Cells were starved over night and incubated for 12 h with or without 100 lM H2O2
and when indicated with 50 ng/ml PDGF-AA. Data were measured in triplicates and represent mean values ± S.D. from at least three independent
experiments. Data were normalized by the apoptosis rate of H2O2-treated cells in the absence of PDGF-AA for each PDGFRA mutant separately.
The relative apoptosis rate for H2O2-treated cells in the absence of PDGF-AA is 1 for each PDGFRA mutant. *P < 0.05 vs. H2O2 alone, **P < 0.01
vs. H2O2 alone and P < 0.05 vs. WT treated with H2O2 in the presence of PDGF-AA.
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Fig. 4. Characterization of PDGFRA-dependent Akt activation. Ph-
cells expressing either the WT or mutant PDGFRs were arrested by
serum deprivation, and exposed to buﬀer () or 50 ng/ml PDGF-AA
for 5 min. The cells were lysed and 30 lg of Triton X-100 soluble lysate
were subjected to a phospho-Akt Western blot analysis. A RasGAP
Western blot was used to demonstrate that similar amounts of protein
were present in all of the samples. (A) Subtraction panel and (B) add-
back panel.
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Fig. 5. PDGF-dependent phosphorylation of Forkhead transcription
factors. Quiescent Ph-cells expressing either the WT, the F72/74, or
the F31/42 PDGFRA (A), or expressing either the WT, the F7 or the
Y31/42 PDGFRA (B) were left resting or stimulated with PDGF-AA
for 30 min as indicated. The cells were lysed, proteins were separated
by SDS–PAGE and subjected to Western blot analysis using anti-
bodies against RasGAP (top lane) and FKHR and FKHRL1 phos-
phorylated at T24 or T32, respectively (bottom lane).
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head transcription factors FKHRL1 and FKHR. To this end,
cells were stimulated with PDGF-AA for 30 min, lysed, and
the site-speciﬁc phosphorylation of FKHR (Threonine 24)
and FKHRL1 (Threonine 32), was analyzed by Western blot-
ting, using phospho-speciﬁc antibodies. As demonstrated in
Fig. 5A, PDGF-AA dependent activation of the WT receptor
caused a signiﬁcant phosphorylation of both FKHR and
FKHRL1 at the respective threonine residues. This eﬀectwas dependent on PI3K-mediated signaling, since the F31/42
receptor did not mediate PDGF-AA-dependent phosphoryla-
tion of Forkhead transcription factors whereas restoration of
the PI3K binding site (Y31/42) rescued phosphorylation of
both FKHR and FKHRL1 (Fig. 5A and B). Interestingly, a
stronger phosphorylation response was observed in the ab-
sence of Src binding (F72/74) (Fig. 5A), which is consistent
with the more pronounced antiapoptotic eﬀect of this receptor
mutant (see Fig. 3A).
In summary, antiapoptotic signaling by the PDGFRA is so-
lely mediated by PI3K, whereas all other receptor-associated
signaling molecules play only a minor role. PI3K/Akt exert
their eﬀects on cell survival via inactivation of proapoptotic
proteins such as Forkhead transcription factors.
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Fig. 6. Src phosphorylates c-Cbl in vitro. C-Cbl was immunoprecip-
itated from serum-deprived Ph-cells and c-Cbl-immunoprecipitates or
mock-immunoprecipitate (left lane) were incubated with various
concentrations of active Src in an in vitro-kinase-assay in the presence
of [c-32P]ATP. Where indicated, the Src inhibitor PP1 was added. The
M. Vantler et al. / FEBS Letters 580 (2006) 6769–6776 67733.3. Src family kinases negatively regulate the antiapoptotic
signal through c-Cbl
Interestingly, PDGFRA-mediated antiapoptotic signaling
was enhanced when the receptor lacks the Src binding site in
the juxtamembrane domain of the receptor (F72/74) (see
Fig. 2A). This may be explained by the previous observation,
that Src is involved in the degradation of the activated
PDGFRA and thus regulates the termination of the PDGFRA’s
signals [24]. Thus, the prolonged half-life of the F72/74 recep-
tor would result in enhanced ligand-induced signaling and pro-
tection against apoptosis. We therefore hypothesized that
deletion of the Src binding site in the F72/74 receptor inﬂu-
ences the PDGFRA’s survival signal through altered signaling
by c-Cbl. We have previously shown that the WT-PDGFRA,
but not the F72/74 mutant, is able to phosphorylate c-Cbl
upon stimulation with PDGF-AA in Ph-cells [24]. To show
that c-Cbl is a direct substrate of Src, c-Cbl was immunopre-
cipitated from Ph-cells, and c-Cbl-immunoprecipitates were
subjected to an in vitro kinase assay in the presence of acti-
vated Src. As shown in Fig. 6, Src directly phosphorylated c-
Cbl in a concentration dependent manner. Furthermore, this
response is depended on Src kinase activity, as the speciﬁc
Src inhibitor PP1 completely suppressed Src dependent phos-
phorylation of c-Cbl.signals were visualized via autoradiography.
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Fig. 7. Src negatively regulates antiapoptotic PDGF-AA signaling via c-Cbl. (A) Expression levels of c-Cbl. Cell lysates from WT or F72/74 cells,
expressing either endogenous levels of c-Cbl () or overexpressing c-Cbl (+), were subjected to Western blot analysis using an PDGFRA antibody
(top panel) or a c-Cbl antibody (bottom panel). (B) Quiescent Ph-cells expressing the WT- or F72/74-PDGFRA that express either normal levels of c-
Cbl (empty vector) or overexpress c-Cbl, were treated 12 h with or without 100 lM H2O2 as indicated in the absence or presence of PDGF-AA
(50 ng/ml). Quantitative analysis of apoptosis by cell death detection ELISA. Data were measured in triplicates and normalized by the apoptosis rate
of the respective H2O2 treated cells (100%). Data represent mean values ± S.D. from at least three independent experiments. *P < 0.05 vs H2O2 alone.
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Fig. 8. Activation of Src impairs phosphorylation of Akt. Ph-cells expressing either the WT- (A) or F72/74-PDGFRs (B) were arrested by serum
deprivation, and exposed to buﬀer () or 50 ng/ml PDGF-AA for the times indicated. The cells were lysed and 30 lg of Triton X-100 soluble lysate
were subjected to a phospho-Akt Western blot analysis. A RasGAP Western blot demonstrate that similar amounts of protein were present in all of
the samples. Densitometric analysis from three independent experiments was performed. Data are expressed as mean values ± S.D. (bottom), and are
normalized for the respective RasGAP values.
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of c-Cbl is responsible for the negative regulation of
PDGFRA-dependent survival signaling by Src, we have over-
expressed c-Cbl in WT as well as in F72/74 expressing Ph-cells
(Fig. 7A). As overexpression of c-Cbl in WT receptor express-
ing cells reversed PDGF-AA-mediated protection against
apoptosis whereas it had no eﬀect on cellular survival in
F72/74 expressing cells (Fig. 7B). These results demonstrate
that Src-mediated phosphorylation of c-Cbl negatively regu-
lates PDGF-AA-induced protection against apoptosis. This
is further supported by the fact that the prolonged half-life
of the F72/74 receptor led to an enhancement of PDGF-in-
duced activation of Akt (Fig. 8A and B). When the kinetics
of PDGF-dependent activation of Akt in WT and F72/74
expressing cells were compared, Akt was maximally phosphor-
ylated 5 min after PDGF stimulation in WT receptor express-
ing cells, and the signal declined to near baseline levels by 8 h.
In contrast, the F72/74 receptor triggered a stronger and pro-
longed response, which was also maximal at 5 min but only
declined slightly during the observation period of 8 h.
In summary, our data demonstrate that Src family kinases
negatively regulate the antiapoptotic eﬀect of PDGF-AA in
ﬁbroblasts, as they promote the termination of the PDGFRA’s
signal through interaction with c-Cbl.4. Discussion
In this study, we have addressed the relative importance
of the signaling enzymes that are recruited to the activated
PDGFRA for cell survival in a single cell line. We found that
activation of the WT PDGFRA signiﬁcantly reduced H2O2-
induced apoptosis. Our study reveals that this eﬀect is mainly
mediated by PI3K-induced Akt activation/phosphorylation
and inactivation of proapoptotic Forkhead transcription fac-
tors, whereas other receptor-associated signaling enzymes(Src, PLC-c, SHP-2) play only a minor role. Conversely, we
demonstrate that Src negatively regulates PDGF-AA-depen-
dent cell survival, as it phosphorylates the ubiquitin ligase c-
Cbl, which is required for the degradation of the activated
PDGFRA.
To identify the signal relay mechanisms that are critical for
PDGFRA-mediated protection against apoptosis, we altered
the ability of the receptor to recruit receptor-associated signal-
ing molecules by speciﬁc tyrosine to phenylalanine substitu-
tions. Using these PDGFRA mutants, we demonstrate that
PDGF-AA-dependent cellular survival signaling requires sta-
ble association of the receptor with PI3K. This was found by
both the subtraction (F31/42) and the add-back approach
(Y31/42), and conﬁrmed by pretreatment of WT, F72/74 or
Y31/42 expressing Ph-cells with the PI3K inhibitor wortman-
nin which also abolished PDGF-dependent protection against
apoptosis (data not shown), indicating that PI3K activity is
important. To this point, our data are consistent with numer-
ous studies demonstrating a prominent role of PI3K in sur-
vival signaling [28].
Although we identiﬁed PI3K as the critical signaling enzyme
for PDGF-AA-dependent protection against apoptosis in Ph-
cells, analysis of the subtraction panel revealed that mutations
of Tyr 720 (responsible for SHP-2 binding), as well as Tyr 988
(binding site of a yet unidentiﬁed signaling molecule) pre-
vented PDGF-AA-mediated cell survival to some extent. Wu
and co-workers demonstrated that SHP-2 is necessary for
growth factor dependent PI3K/Akt activation in mouse ﬁbro-
blasts [25]. They speculate that PI3K and SHP-2 associate with
one or more adaptor proteins. Consistently, Ivins Zito and co-
workers demonstrated that overexpression of dominant nega-
tive SHP-2 diminishes insulin-like growth factor-1-induced
activation of PI3K [26]. Hence, it is possible that prevention
of SHP-2 binding to the activated PDGFRA by the F720
mutation diminishes PI3K activation and thus impairs
PDGF-AA-mediated antiapoptotic signaling. The role of Tyr
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can speculate that phosphorylated Y988 possibly recruits a so
far unidentiﬁed adaptor protein which is a component of the
PI3K/SHP-2 signaling complex. A recent study from Karen
Symes laboratory demonstrated that PI3K and PLC-c are
both necessary for PDGFRA-mediated cell survival during
embryogenesis of Xenopus [27]. In contrast, our results indi-
cate, that PLC-c plays no signiﬁcant role in antiapoptotic sig-
naling in mouse ﬁbroblasts, because the F1018 mutant
protected from apoptosis as eﬃciently as the WT receptor. In-
deed, the F1018 mediated protection against apoptosis seems
to even be more pronounced rather than less eﬃcient com-
pared to the WT receptor-induced antiapoptotic eﬀect, indicat-
ing a possible proapoptotic function of PLC-c. However, the
diﬀerence between WT and F1018 mediated cell survival is
not signiﬁcant, and the Y1018 mutant which binds only
PLC-c did not induce apoptosis. Thus, a proapoptotic func-
tion of PLC-c is unlikely and its antiapoptotic function in cel-
lular survival may be restricted to Xenopus. Furthermore, our
results are consistent with a recent study demonstrating that
only PI3K is important for PDGFRB-dependent survival sig-
naling in vascular smooth muscle cells [28].
The characterization of the downstream events that mediate
PDGFRA-induced cell survival revealed that PI3K initiates
the phosphorylation of Akt, which in turn promotes the phos-
phorylation of FKHR and FKHRL1 at typical phosphoryla-
tion sites for Akt. Akt was previously shown to exert its
antiapoptotic properties by phosphorylation and thus inactiva-
tion of proapoptotic factors including BAD [7] and Forkhead
transcription factors such as FKHR and FKHRL1 [8,29]. Akt-
dependent phosphorylation of FKHR and FKHRL1 leads to
association with 14-3-3 proteins and retention of Forkhead
transcription factors in the cytoplasm. In contrary, dephos-
phorylation of FKHR and FKHRL1 promotes nuclear trans-
location, and the induction of genes that are critical for
apoptosis, such as the Fas ligand gene [8]. In contrast to Fork-
head transcription factors, we did not detect PDGFRA-in-
duced phosphorylation of the proapoptotic Bcl2-protein
BAD as shown for other growth factors, although BAD is ex-
pressed in Ph-cells (data not shown), arguing against a prom-
inent role for BAD phosphorylation in PDGF-AA-mediated
protection against apoptosis.
Interestingly, the activated F72/74 mutant, which is not able
to bind or activate Src family kinases, exerted a signiﬁcantly
more pronounced antiapoptotic eﬀect than the WT receptor
(reduction of H2O2-induced apoptosis 54.8 ± 4.0% vs. 20.1 ±
8.2%). A possible proapoptotic function of Src is unlikely,
because activation of the Y72/74 mutant, which binds and acti-
vates only Src, did not increase apoptosis. Hence, our data
suggest that Src negatively regulates survival signaling by
the PDGFRA. This is strongly supported by the fact that
the F72/74 mediated Akt activation persists longer than the
respective WT induced signal. Consistently, Akt-dependent
phosphorylation of Forkhead transcription factors is more
pronounced in the absence of Src binding. Src was previously
shown to negatively regulate PDGFRA-mediated signaling by
phosphorylation of the ubiquitin ligase c-Cbl, thereby inducing
the degradation of the activated PDGFRA [24,30]. To test the
hypothesis that Src negatively regulates antiapototic signaling
by the PDGFRA through c-Cbl, we investigated whether the
expression level of c-Cbl inﬂuences the antiapoptotic eﬀect of
the WT or the F72/74 mutant, respectively. Overexpressionof c-Cbl in WT-expressing Ph-cells signiﬁcantly attenuated
PDGF-AA-induced cell survival, whereas Cbl-overexpression
had no eﬀect in F72/74-expressing cells. These data strongly
indicate that c-Cbl-mediated degradation of the PDGFRA is
responsible for the comparably weak antiapoptotic eﬀect of
the activated WT receptor. Furthermore, c-Cbl-mediated sup-
pression of PDGFRA-induced cell survival depends exclu-
sively on the activation of Src. The cytoplasmic tyrosine
kinase Src may either directly phosphorylate c-Cbl, or it func-
tions as an adaptor protein to bring c-Cbl to the receptor.
Using an in vitro kinase assay, we were able to show, that
c-Cbl is a direct substrate of Src family kinases. Thus, Src ki-
nases negatively regulate antiapoptotic signaling by phosphor-
ylating c-Cbl, which in the phosphorylated state terminates the
PDGFR’s signal by promoting receptor degradation. These
ﬁndings are consistent with our previous observation that the
F72/74 receptor has a prolonged half life and mediates a stron-
ger mitogenic signal compared to the WT receptor [3]. Hence,
Src family kinases appear to negatively regulate PDGF-AA
dependent cell survival by terminating PDGFRA signaling.
The activated Y31/42 mutant which binds and activates only
PI3K was not as eﬃcient in protecting from apoptosis as
the F72/74 mutant (reduction of H2O2-induced apoptosis
31.1 ± 5.5% vs. 54.8 ± 4.0%) but more eﬀective than the WT
receptor (20.1 ± 8.2%). Like the F72/74 receptor, the Y31/42
mutant is not able to bind Src family kinases explaining the
trend to a more pronounced antiapoptotic eﬀect compared
to the WT receptor. However, in contrast to the F72/74 recep-
tor, the Y31/42 mutant does not comprise the binding sites at
tyrosines 720 and 988, which may also inﬂuence PDGFRA-
mediated cell survival and may be required for full activation
of PI3K.
In summary, the direct comparison of the various signaling
pathways that are activated in a PDGF-stimulated cell demon-
strates that only one signaling enzyme recruited to the
PDGFRA, PI3K, is necessary and suﬃcient for PDGFRA-
mediated cell survival. Only PI3K is able to eﬃciently activate
the antiapoptotic Akt signaling pathway and mediates its
survival eﬀects via inactivation of proapoptotic Forkhead
transcription factors. PDGFRA-induced cell survival is nega-
tively regulated by Src family kinases, which regulate the deg-
radation of the activated receptor via phosphorylation of c-Cbl
leading to an attenuation of the antiapoptotic PI3K/Akt sig-
naling pathway.
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